Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: A case-control study
P. Xiong et al., Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: A case-control study, CANCER RES, 61(23), 2001, pp. 8465-8469
Mounting epidemiological evidence suggests that smoking may play a role in
the etiology of breast cancer. Because smoking-related DNA adducts are dete
ctable in both normal and malignant breast tissues, we hypothesized that br
east cancer patients may be sensitive to tobacco-induced carcinogenesis, an
d this sensitivity could be modulated by variants of metabolic genes. To te
st this hypothesis, we evaluated benzo(a)pyrene diol-epoxide (BPDE)-induced
mutagen sensitivity and polymorphisms of GSTM1 and GSTT1 in a pilot case-c
ontrol study of breast cancer. Short-term cell cultures were established fr
om blood samples of 100 female breast cancer patients and 105 healthy contr
ols. After 5 h of in vitro exposure to 4 muM of BPDE, we harvested the lymp
hocytes for cytogenetic evaluation and recorded and compared the frequency
of BPDE-induced chromatid breaks between cases and controls. We used a mult
iplex PCR-based assay to simultaneously detect polymorphisms of GSTM1 and G
STT1 from genomic DNA. We performed univariate and multivariate logistic re
gression analyses and calculated odds ratios (OR) and 95% confidence interv
als (CIs). Cases had a significantly higher frequency of chromatid breaks t
han did controls (P < 0.0001). The level of chromatid breaks greater than t
he median value of controls was associated with a >3-fold increased risk of
breast cancer [adjusted odds ratio (ORadj) = 3.11; 95% CI = 1.72-5.64]. Th
e risk was more pronounced in those who were < 45 years (ORadj = 4.79; 95%
CI = 1.87-12.3), ever-smokers (ORadj = 5.55; 95% CI = 1.85-16.6), alcohol d
rinkers (ORadj = 4.64; 95% CI = 1.70-12.7), and those who had the GSTT1 nul
l variant (ORadj = 8.01; 95% CI = 1.16-55.3). These data suggest that sensi
tivity to BPDE-induced chromosomal aberrations may contribute to the risk o
f developing breast cancer, and such sensitivity may be modulated by both g
enetic and environmental factors. Larger studies are needed to confirm our
findings.